DFS
64
2
JBHT
56
-3
EOG
56
-2
CNP
54
10
CB
57
2
SYY
49
9
GME
66
-5
KR
36
-6
HCA
48
-2
RRC
52
-6
HST
39
-3
MAR
63
-5
AAPL
40
-6
THC
60
-5
TMO
42
-6
CI
45
-3
TGNA
50
-6
ECL
55
-2
M
31
-3
MNST
45
-21
DFS
64
2
JBHT
56
-3
EOG
56
-2
CNP
54
10
CB
57
2
SYY
49
9
GME
66
-5
KR
36
-6
HCA
48
-2
RRC
52
-6
HST
39
-3
MAR
63
-5
AAPL
40
-6
THC
60
-5
TMO
42
-6
CI
45
-3
TGNA
50
-6
ECL
55
-2
M
31
-3
MNST
45
-21
Financhill
Back

First Trust Switzerland AlphaDEX® ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
50

FSZ
First Trust Switzerland AlphaDEX® ETF

Last Price:
67.04
Seasonality Move:
4.48%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
50
First Trust Switzerland AlphaDEX® ETF (FSZ) is a Sell

Is First Trust Switzerland AlphaDEX® ETF a Buy, Sell or Hold?

  • The current First Trust Switzerland AlphaDEX® ETF [FSZ] share price is $64.76. The Score for FSZ is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • FSZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FSZ Stock Price Chart

What is First Trust Switzerland AlphaDEX® ETF's stock price today?

  • The First Trust Switzerland AlphaDEX® ETF share price today is $64.76
    The current trend is relatively stagnant and FSZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FSZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 32.11 Sell
Chaikin Money Flow: 1968 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66 - 68.94) Sell
Bollinger Bands (100): (65.55 - 69.13) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FSZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.89 Sell
20-day SMA: 67.06 Sell
50-day SMA: 68.33 Sell
200-day SMA: 65.39 Sell
8-day EMA: 65.63 Sell
20-day EMA: 66.76 Sell
50-day EMA: 67.56 Sell
200-day EMA: 65.69 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Trust Switzerland AlphaDEX® ETF Earnings Growth & FSZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

First Trust Switzerland AlphaDEX® ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):